Clinical potential idiosyncratic toxicities. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Cell Line, Tumor Stem Cells Tumor Cells, Cultured Cell Line Cells, Cultured Liver Kidney Bone Marrow Neurons Lung Hepatocytes Mitochondria

Organisms12

Mice, Nude Mice, Inbred BALB C Mice, Inbred C57BL Rats, Sprague-Dawley Rats, Inbred F344 Daphnia Bacillus thuringiensis Rats, Wistar Artemia Larva Rabbits Mice, Inbred ICR

Diseases45

Neoplasms Disease Models, Animal Leukopenia Drug-Related Side Effects and Adverse Reactions Radiation Injuries Drug-Induced Liver Injury Neutropenia Hematologic Diseases Lung Neoplasms Thrombocytopenia Nausea Neurotoxicity Syndromes Body Weight Neoplasm Metastasis Plant Poisoning Neoplasm Recurrence, Local Stomatitis Breast Neoplasms Adenocarcinoma Abnormalities, Drug-Induced Vomiting Carcinoma, Non-Small-Cell Lung Drug Eruptions Gastrointestinal Diseases Drug Overdose Poisoning Mucositis Colorectal Neoplasms Disease Progression Exanthema Head and Neck Neoplasms Ovarian Neoplasms Prostatic Neoplasms Radiodermatitis Brain Neoplasms Male Urogenital Diseases Lymphoma, Non-Hodgkin Kidney Diseases Necrosis Melanoma Alopecia Diarrhea Kidney Neoplasms Liver Neoplasms Carcinoma, Squamous Cell

Chemicals and Drugs94

Thymidine Monophosphate Spermatocidal Agents Antineoplastic Agents Antibodies, Monoclonal Tumor Markers, Biological Cisplatin Fluorouracil Doxorubicin Deoxycytidine Antineoplastic Agents, Phytogenic Antimetabolites, Antineoplastic Paclitaxel Antidotes Camptothecin Cyclophosphamide Carboplatin Taxoids Teratogens Organoplatinum Compounds Water Pollutants, Chemical Leucovorin Etoposide Environmental Pollutants Glutathione Insecticides Vinblastine Methotrexate Antineoplastic Agents, Alkylating Plant Extracts Vincristine Antibiotics, Antineoplastic Acetaminophen Prodrugs Ifosfamide Cadmium Methylmercury Compounds Dacarbazine Aluminum Cytochrome P-450 CYP2E1 Neurotoxins Dihydrouracil Dehydrogenase (NADP)Drug Carriers Bacterial Toxins Amyloid beta-Peptides Recombinant Proteins Antioxidants Antibodies, Monoclonal, Humanized Bleomycin Reactive Oxygen Species L-Lactate Dehydrogenase Topotecan Amifostine Melphalan Herbicides Immunotoxins Xenobiotics Endotoxins Cytarabine Tetrachlorodibenzodioxin Enzyme Inhibitors Liposomes Toxins, Biological Epirubicin Carmustine Drug Combinations Prednisone Organophosphorus Compounds Quinazolines Thiazoles Superoxide Dismutase Ethylene Glycols Paraquat Yttrium Radioisotopes Selenium Compounds Hazardous Substances Niacinamide Radiation-Sensitizing Agents Mitomycin Peptides Metals, Heavy Mercury Lead Neuroprotective Agents Polyethylene Glycols Carcinogens Mycotoxins Mitoxantrone Copper Phenylurea Compounds Pyridines Benzenesulfonates Amphotericin B Tegafur Guanine

Analytical, Diagnostic and Therapeutic Techniques and Equipment63

Toxicity Tests Drug Evaluation, Preclinical Drug Delivery Systems Gene Transfer Techniques Xenograft Model Antitumor Assays Disease Models, Animal Clinical Trials as Topic Genetic Therapy Treatment Outcome Toxicity Tests, Acute Sensitivity and Specificity Lethal Dose 50 Antineoplastic Combined Chemotherapy Protocols Toxicity Tests, Chronic Drug Administration Schedule Infusions, Intravenous No-Observed-Adverse-Effect Level Maximum Tolerated Dose Administration, Oral Combined Modality Therapy Drug Evaluation Toxicity Tests, Subchronic Survival Analysis Disease-Free Survival Radiotherapy Dosage Survival Rate Animal Testing Alternatives Radiotherapy Organ Size Toxicity Tests, Subacute Dose Fractionation Body Weight Radiotherapy, Conformal Area Under Curve Neoplasm Staging Remission Induction Injections, Intravenous Salvage Therapy Radioimmunotherapy Clinical Trials, Phase I as Topic Drug Carriers Radiotherapy, Intensity-Modulated Follow-Up Studies Drug Overdose Feasibility Studies Chemotherapy, Adjuvant Mutagenicity Tests Retrospective Studies Hematologic Tests Injections, Intraperitoneal Metabolic Clearance Rate Chemoradiotherapy Dose-Response Relationship, Radiation Drug Therapy, Combination Blood Cell Count Prospective Studies Carcinogenicity Tests Models, Biological Biological Assay Injections, Subcutaneous Inhibitory Concentration 50 Pilot Projects Chromatography, High Pressure Liquid

Phenomena and Processes35

Time Factors Cell Proliferation Apoptosis Cell Survival Genetic Vectors Sensitivity and Specificity Cell Differentiation Signal Transduction Dose-Response Relationship, Drug Lethal Dose 50 No-Observed-Adverse-Effect Level Maximum Tolerated Dose Drug Interactions Organ Size Body Weight Area Under Curve Oxidative Stress Tissue Distribution Drug Synergism Cell Death Biotransformation Metabolic Detoxication, Drug Particle Size Drug Resistance, Neoplasm Mutation Molecular Structure Structure-Activity Relationship Metabolic Clearance Rate Dose-Response Relationship, Radiation Blood Cell Count Half-Life Cytoprotection Necrosis Larva Inhibitory Concentration 50

Disciplines and Occupations3

Toxicology Toxicogenetics Ecotoxicology

Technology, Industry, Agriculture4

Nanoparticles Metal Nanoparticles Liposomes Polyethylene Glycols

Information Science3

Survival Rate Radiotherapy, Conformal Radiotherapy, Intensity-Modulated

Health Care17

Clinical Trials as Topic Treatment Outcome Sensitivity and Specificity Radiation Injuries Survival Analysis Disease-Free Survival Survival Rate Area Under Curve Clinical Trials, Phase I as Topic Follow-Up Studies Feasibility Studies Retrospective Studies Dose-Response Relationship, Radiation Prospective Studies Societies, Scientific Pilot Projects Inhalation Exposure

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Thymidine Monophosphate Spermatocidal Agents Neoplasms Antineoplastic Agents Toxicity Tests Drug Evaluation, Preclinical Cell Line, Tumor Mice, Nude Drug Delivery Systems Gene Transfer Techniques Xenograft Model Antitumor Assays Disease Models, Animal Mice, Inbred BALB C Time Factors Cell Proliferation Apoptosis Clinical Trials as Topic Cell Survival Genetic Therapy Treatment Outcome Genetic Vectors Antibodies, Monoclonal Toxicity Tests, Acute Stem Cells Mice, Inbred C57BL Tumor Cells, Cultured Rats, Sprague-Dawley Tumor Markers, Biological Sensitivity and Specificity Cell Differentiation Cell Line Cells, Cultured Signal Transduction Dose-Response Relationship, Drug Lethal Dose 50 Antineoplastic Combined Chemotherapy Protocols Toxicity Tests, Chronic Drug Administration Schedule Cisplatin Infusions, Intravenous No-Observed-Adverse-Effect Level Fluorouracil Maximum Tolerated Dose Administration, Oral Doxorubicin Combined Modality Therapy Toxicology Deoxycytidine Drug Evaluation Leukopenia Antineoplastic Agents, Phytogenic Drug-Related Side Effects and Adverse Reactions Antimetabolites, Antineoplastic Radiation Injuries Paclitaxel Drug-Induced Liver Injury Liver Neutropenia Toxicity Tests, Subchronic Antidotes Survival Analysis Camptothecin Cyclophosphamide Disease-Free Survival Radiotherapy Dosage Carboplatin Hematologic Diseases Lung Neoplasms Taxoids Teratogens Survival Rate Organoplatinum Compounds Water Pollutants, Chemical Leucovorin Thrombocytopenia Etoposide Animal Testing Alternatives Environmental Pollutants Glutathione Insecticides Vinblastine Methotrexate Radiotherapy Antineoplastic Agents, Alkylating Drug Interactions Organ Size Nausea Toxicity Tests, Subacute Neurotoxicity Syndromes Plant Extracts Dose Fractionation Vincristine Body Weight Antibiotics, Antineoplastic Nanoparticles Radiotherapy, Conformal Area Under Curve Oxidative Stress Neoplasm Staging Kidney

No FAQ available that match "clinical potential idiosyncratic toxicities"